Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Prostatic Neoplasms 22Breast Neoplasms 21Polycystic Ovary Syndrome 12Carcinoma, Non-Small-Cell Lung 11Colorectal Neoplasms 10Lung Neoplasms 8Endometrial Neoplasms 7Pancreatic Neoplasms 6Neoplasms 6Glioblastoma 5Rectal Neoplasms 4Melanoma 4Lymphoma, Large B-Cell, Diffuse 4Insulin Resistance 4Adenocarcinoma of Lung 4Adenocarcinoma 4Uterine Cervical Neoplasms 3Leukoplakia, Oral 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Obesity 2Neoplasm Metastasis 2Liver Neoplasms 2Leukemia, Myeloid, Acute 2Hyperandrogenism 2Esophageal Neoplasms 2Erythroplasia 2Endometrial Hyperplasia 2Diabetes Mellitus 2Colonic Neoplasms 2

Interventions

Sorafenib 3cabozantinib 2vandetanib 1temsirolimus 1pembrolizumab 1lenvatinib 1apatinib 1Vitamin B 12 1Thyrotropin-Releasing Hormone 1Pemetrexed 1Panobinostat 1Metformin 1Folic Acid 1Fluorescein 1Everolimus 1Cisplatin 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Thyroid Diseases × Metformin × Clear all
NCT03109847 2025-12-11

Metformin to Mitigate Sequelae of Radioactive Iodine Treatment for Thyroid Cancers

Thomas Jefferson University

Phase 2 Terminated
13 enrolled 8 charts
Head & Neck

Thyroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡